Matthew is an accomplished biotech executive with experience working in both start-up and growth-stage companies. His technical expertise spans protein engineering, drug discovery, advanced biomanufacturing, and synthetic biology. His efforts have led to successfully commercialized technologies or partnerships with top-10 pharma companies.